SlideShare une entreprise Scribd logo
1  sur  31
REGENCY INSTITUTE OF NURSING
TOPIC- CORONARY ARTERY DISEASE
BY- SHREYA YADAV
NURSING TUTOR
MEDICAL SURGICAL
NURSING
DEFINITION
 Coronary artery disease is the narrowing or blockage of the
coronary arteries, usually caused by atherosclerosis.
 CAD is a progressive disease process characterized by
narrowing or blockage of coronary artery resulting in
decreased blood flow to the heart muscle.
RISK FACTOR
MODIFIABLE RISK FACTORS:
 Tobacco use
 High blood cholesterol or triglyceride levels
 Lack of exercise
 Obesity
 Stress
 Use of oral contraceptive
 Infection
 Hypertension
NONMODIFIABLE RISK FACTORS:
 Family history of heart disease
 Age (45-55)
 Gender
CLINICAL MANIFESTATION:
 Ischemia
 Low cardiac output
 Bradycardia (Decrease pulse rate)
 Hypertension
 Myocardial infarction
 Diaphoresis –excessive sweating
 ECG changes – ST segment and T wave changes, also show
tachycardia, bradcardia, or dysrhythimas.
 Dysarrithmias
 Decreased urine output.
 Nausea And Vomiting
 Skin- Cool, Clammy ,Diaphoretic , And Pale Appearance
On Skin.
DIAGNOSTIC EVALUATION:
History collection
Physical examination
Stress test
Chest x ray
ECG
Echocardiogram
Cardiac Catheterization
MANAGEMENT
MEDICAL MANAGEMENT
Vasodilators (These drugs acts as blood vessel dilator):
Nitrates.
Beta-Blockers (Decrease work load in heart):
Propranolol 20-40 mg.
Calcium channel blocker They improve coronary blood
flow:
 Nifedipine
 Verapamil
Anti-hypertensive drugs
 Methyldopa, Sodium nitroprusside, Amlodipine.
ACE inhibitor
 Captopril, Enolapril
SURGICAL MANAGEMENT
• Percutaneous transluminal coronary angioplasty(PTCA).
• Coronary artery bypass graft surgery(DCA).
• Intra coronary stent.
NURSING MANAGEMENT
• Assess pain
• Assess vital sign
• Ensure bed rest
• Continuous cardiac monitoring
Angina Pectoris
Angina pectoris is a sudden attacks of chest pain or
discomfort caused by deficient oxygenation of the heart
muscles usually due to impaired blood flow to the heart
Modifiable risk factor:
 Tobacco use
 High blood cholesterol or triglyceride levels
 Lack of exercise
 Obesity
 Stress
NON MODIFIABLE RISK FACTORS:
 Family history of heart disease
 Age
 Gender
CLINICAL MANIFESTATION:
Sensation of chest pain.
Ischemia- Ischemia is a restriction in blood supply to
tissues, causing a shortage of oxygen that is needed for
cellular.
Low cardiac output
Decrease pulse rate.
BP may be elevated because of sympathetic stimulation or
decreased BP because of decreased contractility.
Myocardial infarction
Diaphoresis –excessive sweating
ECG changes – ST segment and T wave changes
 Pulmonary edema
 Chest heaviness
 Dyspnea- difficulity of breathing
 Fatigue
 Gastrointestinal- Nausea And Vomiting
 Skin- Cool, Clammy ,Diaphoretic , And Pale Appearance On
Skin
DIAGNOSTIC EVALUATION:
• History collection
• Stress test
• Electrocardiogram(ECG)
• Echocardiogram
• Angiogram
MANAGEMENT
Can be used to treat coronary artery disease,
including:
 Vasodilators (These drugs acts as blood vessel
dilator):
 Nitrates
 Beta-Blockers (Decrease work load in heart): •
Propranolol 20-40 mg
 Calcium channel blocker (They improve coronary
blood flow): Nifedipine , Verapamil
Atheriosclerosis
Atherosclerosis is the most
common disease of the
arteries; the term means
“hardening of the arteries. It
is the diffuse process
whereby the muscle fibers
and the endothelial lining of
the walls of small arteries
and arterioles become
thickened.
Risk Factor-
 High blood pressure
 High cholesterol
 High triglycerides, a type of fat (lipid) in your blood
 Smoking and other sources of tobacco
 Insulin resistance, obesity or diabetes
 A family history of early heart disease
 Lack of exercise
CLINICAL MANIFESTATION-
 Pain is the first symptom that occurs
 Pain generally occurs in the affected extremity in conjunction
w/sustained activity. This is due to the demand of the tissue
exceeding the available blood supply.
 Heart failure
 Increased cardiac enzyme level
 Sudden cardiac death
 Dyspnea
 Inadequate cardiac output
 Ischemia of heart muscles
 Difficulty in speaking
 Arrythmias
 Palpitation
 Diaphoresis
 Myocardial infraction
 Diagnostic Evaluation-
 History collection – The family history, nutritional
history and personal history should be collected from
the patient.
 Physical examination
 Blood studies
 Electrocardiogram (ECG)
 Angiogram
 CT-Scan
MANAGEMENT-
Pharmacological management-
 Anti-platelet medications. Such as aspirin(75-100mg,orally).
 Beta blocker medications Eg: propanolol (20-40 mg).
 Angiotensin-converting enzyme (ACE) inhibitors.. Eg:
captopril(25 mg orally) ramipril(20mg orally).
 Calcium channel blockers. Eg: verapamil amlodipin (5-20 mg
IV).
Surgical Management:
 Coronary Artery Bypass Surgery. (CABG)
 Thrombectomy
 Embolectomy
MYOCARDIAL INFRACTION
Myocardial Infarction is defined as a disease caused by
reduced blood flow in a coronary artery due to
atherosclerosis & occlusion of an artery an embolus or
thrombus.
Types of Myocardial infarction-
According to wall-
 Anterior wall MI- obstruction of left anterior descending
artery (LAD) results in anterior or septal wall MI
 Posterior wall MI – Obstruction of circumflex artery
results in posterior wall MI.
 Inferior wall MI- obstruction of the right coronary artery
results in inferior wall MI.
According to ECG
 ST-Elevated Myocardial infarction
 Non- ST Elevated Myocardial Infarction
RISK FACTORS
Non- Modifiable Risk Factors:
 Age(45-55)
 Gender
 Sex (Male)
 Genetics
Modifiable Risk Factors:
 Tobacco use
 High blood cholesterol or triglyceride levels
 Lack of exercise
 Obesity
 Stress
 Use of oral contraceptive
 Infection
 Hypertension
CLINICAL MANIFESTATION
 Chest pain characterized by
 heavy, vise like pain which radiates to shoulders and down the arms, usually the
left arms
 occur during rest and during exertion
 not relieved by rest long lasts longer than 30 min.
 No relief with nitrites
 Shortness of breath
 Pallor
 Cold clammy skin
 Diaphoresis
 Dizziness
 Light headedness
 Nausea
 Vomiting
 Fainting
 Shock
 Profuse sweating
 Fever after 48 hour of MI
 Pulse normal often rapid or irregular
 Anxiety
DIAGNOSTIC EVALUATION
 History collection
 Physical examination
 Electrocardiogram
 Echocardiogram
 Cardiac marker-
 Myoglobin-The myoglobin level starts to increase within 1 to 3 hours
and peaks within 12 hours after the onset of symptoms.
 Troponin- Troponin I and T are specific for cardiac muscle, an increase
in the level of troponin in the serum can be detected within a few hours
during acute MI.
 Creatine Kinase and Its Isoenzymes-There are three creatine kinase
(CK) isoenzymes: CK-MM (skeletal muscle), CK-MB (heart muscle),
and CK-BB (brain tissue).
MANAGEMENT-
MEDICAL MANAGEMENT-
Pharmacological management-
 Opiate Analgesic - Morphine (2.5-5.0mg, IV) - For sudden relief of
pain & anxiety.
 Aspirin (162-325mg,Orally)- for prevention of thrombus
extension, embolism, venous thrombosis
 Vasodilators- Nitrates (0.4 mg , sublingual)
 Anticoagulant- Heparin (5000 U,IV)
 Antihypertensive drugs-Methyldopa- (250 mg. orally), B- blocker-
Propanolol(20- 40 mg).
Non-pharmacological management-
 Avoiding tobacco smoking, eating a well-balanced diet that
is low in saturated fat and refined carbohydrates.
 Cessation of smoking should be given priority in risk-factor
reduction.
 Regular physical activity reduces the incidence of, and
fatality rate from, cardiovascular disease.
Surgical management-
 Coronary artery bypass graft surgery (CABG)
 (PTCA) percutaneous transluminal coronary angioplasty - a
small, flexible plastic tube, or catheter, with a "balloon" at the end
of it. When the tube is in place, it inflates to open the blood vessel.
 Atherectomy
NURSING MANAGEMENT:
- Assess vita sign of the patient.
- Assess for the chest pain where it radiates
- Advice to do not smoke and drink alcohol.
- Change the position to maintain blood circulation.
- Provide adequate bed rest.
NURSING DIAGNOSIS
 Acute Pain related to decreased/increased cardiac output as
evidenced by verbalization.
 Ineffective breathing pattern related to decreased blood
flow to pulmonary capillaries secondary to decreased
ventricular contractility as evidenced by vital sign.
 Impaired tissue perfusion related to decreased cardiac
output as evidence by vital sign.
 Fear and anxiety related to disease condition as evidence by
facial expression.
 Knowledge deficit related to prognosis and self care
management as evidence patient is asking more question.

Contenu connexe

Similaire à CORONARY ARTERY DISEASE.pptx

CARDIOGENIC SHOCK
CARDIOGENIC SHOCKCARDIOGENIC SHOCK
CARDIOGENIC SHOCKMahi Yeruva
 
Acute myocardial infraction
Acute myocardial infractionAcute myocardial infraction
Acute myocardial infractionNetraGautam
 
Ischemic heart disease
Ischemic heart diseaseIschemic heart disease
Ischemic heart diseaseTsegaye Melaku
 
Coronary Artery Disease / Acute Myocardial Infarction ppt
Coronary Artery Disease / Acute Myocardial Infarction pptCoronary Artery Disease / Acute Myocardial Infarction ppt
Coronary Artery Disease / Acute Myocardial Infarction pptHaroldVelaydez1
 
CAD AND MI (CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTION)
CAD AND MI (CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTION)CAD AND MI (CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTION)
CAD AND MI (CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTION)kalyan kumar
 
Cardiovascular
CardiovascularCardiovascular
CardiovascularGAILyum
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarctionV4Veeru25
 
Coronary artery disease
Coronary artery diseaseCoronary artery disease
Coronary artery diseasesonia dagar
 
myocardialinfractionramesh-170504133703 (1).pdf
myocardialinfractionramesh-170504133703 (1).pdfmyocardialinfractionramesh-170504133703 (1).pdf
myocardialinfractionramesh-170504133703 (1).pdfjiregnaetichadako
 
CARDIAC EMERGENCY
CARDIAC EMERGENCYCARDIAC EMERGENCY
CARDIAC EMERGENCYShalu Udhay
 
Myocardial Infarction
Myocardial Infarction Myocardial Infarction
Myocardial Infarction Toukir Ahamed
 
Presentation MI final by Dr Nasir Uddn
Presentation MI final by Dr Nasir Uddn Presentation MI final by Dr Nasir Uddn
Presentation MI final by Dr Nasir Uddn Nasir Sagar
 

Similaire à CORONARY ARTERY DISEASE.pptx (20)

CARDIOGENIC SHOCK
CARDIOGENIC SHOCKCARDIOGENIC SHOCK
CARDIOGENIC SHOCK
 
Acute myocardial infraction
Acute myocardial infractionAcute myocardial infraction
Acute myocardial infraction
 
I s c h a e m i a
I s c h a e m i aI s c h a e m i a
I s c h a e m i a
 
Ischemic heart disease
Ischemic heart diseaseIschemic heart disease
Ischemic heart disease
 
Coronary Artery Disease / Acute Myocardial Infarction ppt
Coronary Artery Disease / Acute Myocardial Infarction pptCoronary Artery Disease / Acute Myocardial Infarction ppt
Coronary Artery Disease / Acute Myocardial Infarction ppt
 
ANGINA.pptx
ANGINA.pptxANGINA.pptx
ANGINA.pptx
 
Angina pectoris
Angina pectorisAngina pectoris
Angina pectoris
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
CAD AND MI (CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTION)
CAD AND MI (CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTION)CAD AND MI (CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTION)
CAD AND MI (CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTION)
 
Cardiovascular
CardiovascularCardiovascular
Cardiovascular
 
CPR 2.pptx
CPR 2.pptxCPR 2.pptx
CPR 2.pptx
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Coronary artery disease
Coronary artery diseaseCoronary artery disease
Coronary artery disease
 
myocardialinfractionramesh-170504133703 (1).pdf
myocardialinfractionramesh-170504133703 (1).pdfmyocardialinfractionramesh-170504133703 (1).pdf
myocardialinfractionramesh-170504133703 (1).pdf
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Antianginals
AntianginalsAntianginals
Antianginals
 
CARDIAC EMERGENCY
CARDIAC EMERGENCYCARDIAC EMERGENCY
CARDIAC EMERGENCY
 
Coronary heart disease
Coronary heart diseaseCoronary heart disease
Coronary heart disease
 
Myocardial Infarction
Myocardial Infarction Myocardial Infarction
Myocardial Infarction
 
Presentation MI final by Dr Nasir Uddn
Presentation MI final by Dr Nasir Uddn Presentation MI final by Dr Nasir Uddn
Presentation MI final by Dr Nasir Uddn
 

Plus de ShreyaYadav35

Malignant Melanoma.pptx
Malignant Melanoma.pptxMalignant Melanoma.pptx
Malignant Melanoma.pptxShreyaYadav35
 
Acne,eczema and pemphigus.pptx
Acne,eczema and pemphigus.pptxAcne,eczema and pemphigus.pptx
Acne,eczema and pemphigus.pptxShreyaYadav35
 
Specific age competencies ppt
Specific age competencies pptSpecific age competencies ppt
Specific age competencies pptShreyaYadav35
 
Safeinjectionpractices ppt
Safeinjectionpractices pptSafeinjectionpractices ppt
Safeinjectionpractices pptShreyaYadav35
 
Movementdisorder 190831154841 (1)
Movementdisorder 190831154841 (1)Movementdisorder 190831154841 (1)
Movementdisorder 190831154841 (1)ShreyaYadav35
 
Meningitis AND encephlitis 170131181426-converted
Meningitis AND encephlitis 170131181426-convertedMeningitis AND encephlitis 170131181426-converted
Meningitis AND encephlitis 170131181426-convertedShreyaYadav35
 
Intervertebraldiscprolapseivdp 171013100709-converted
Intervertebraldiscprolapseivdp 171013100709-convertedIntervertebraldiscprolapseivdp 171013100709-converted
Intervertebraldiscprolapseivdp 171013100709-convertedShreyaYadav35
 
Bellspalsy 130915141951-phpapp02-converted
Bellspalsy 130915141951-phpapp02-convertedBellspalsy 130915141951-phpapp02-converted
Bellspalsy 130915141951-phpapp02-convertedShreyaYadav35
 
Msn ist(gnm 2nd yr) unit-neuro
Msn ist(gnm 2nd yr)   unit-neuroMsn ist(gnm 2nd yr)   unit-neuro
Msn ist(gnm 2nd yr) unit-neuroShreyaYadav35
 
Msn ist(gnm 2nd yr) unit-neuro trauma copy
Msn ist(gnm 2nd yr)   unit-neuro trauma copyMsn ist(gnm 2nd yr)   unit-neuro trauma copy
Msn ist(gnm 2nd yr) unit-neuro trauma copyShreyaYadav35
 

Plus de ShreyaYadav35 (20)

Malignant Melanoma.pptx
Malignant Melanoma.pptxMalignant Melanoma.pptx
Malignant Melanoma.pptx
 
FRACTURE PPT.pptx
FRACTURE PPT.pptxFRACTURE PPT.pptx
FRACTURE PPT.pptx
 
Alopecia.pptx
Alopecia.pptxAlopecia.pptx
Alopecia.pptx
 
Acne,eczema and pemphigus.pptx
Acne,eczema and pemphigus.pptxAcne,eczema and pemphigus.pptx
Acne,eczema and pemphigus.pptx
 
Specific age competencies ppt
Specific age competencies pptSpecific age competencies ppt
Specific age competencies ppt
 
Safeinjectionpractices ppt
Safeinjectionpractices pptSafeinjectionpractices ppt
Safeinjectionpractices ppt
 
Triage ppt
Triage pptTriage ppt
Triage ppt
 
Hand hygiene
Hand hygieneHand hygiene
Hand hygiene
 
Parkinsonism
ParkinsonismParkinsonism
Parkinsonism
 
Movementdisorder 190831154841 (1)
Movementdisorder 190831154841 (1)Movementdisorder 190831154841 (1)
Movementdisorder 190831154841 (1)
 
Meningitis AND encephlitis 170131181426-converted
Meningitis AND encephlitis 170131181426-convertedMeningitis AND encephlitis 170131181426-converted
Meningitis AND encephlitis 170131181426-converted
 
Intervertebraldiscprolapseivdp 171013100709-converted
Intervertebraldiscprolapseivdp 171013100709-convertedIntervertebraldiscprolapseivdp 171013100709-converted
Intervertebraldiscprolapseivdp 171013100709-converted
 
Encephalitis
EncephalitisEncephalitis
Encephalitis
 
Dystrophy ppt
Dystrophy pptDystrophy ppt
Dystrophy ppt
 
Cerebral edema
Cerebral edemaCerebral edema
Cerebral edema
 
Brain tumor
Brain tumorBrain tumor
Brain tumor
 
Bellspalsy 130915141951-phpapp02-converted
Bellspalsy 130915141951-phpapp02-convertedBellspalsy 130915141951-phpapp02-converted
Bellspalsy 130915141951-phpapp02-converted
 
Brain tumor
Brain tumorBrain tumor
Brain tumor
 
Msn ist(gnm 2nd yr) unit-neuro
Msn ist(gnm 2nd yr)   unit-neuroMsn ist(gnm 2nd yr)   unit-neuro
Msn ist(gnm 2nd yr) unit-neuro
 
Msn ist(gnm 2nd yr) unit-neuro trauma copy
Msn ist(gnm 2nd yr)   unit-neuro trauma copyMsn ist(gnm 2nd yr)   unit-neuro trauma copy
Msn ist(gnm 2nd yr) unit-neuro trauma copy
 

Dernier

DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRYDEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRYChsaiteja3
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesTina Purnat
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)Monika Kanwar
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgeryKafrELShiekh University
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Catherine Liao
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Catherine Liao
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthCatherine Liao
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1DR SETH JOTHAM
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxSergio Pinski
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxDr KHALID B.M
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxdrwaque
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghanahealthwatchghana
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAkashGanganePatil1
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxSamar Tharwat
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communicationskatiequigley33
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptdesktoppc
 
CNN-based plastic waste detection system
CNN-based plastic waste detection systemCNN-based plastic waste detection system
CNN-based plastic waste detection systemBOHRInternationalJou1
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartMedicoseAcademics
 

Dernier (20)

DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRYDEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
DEVELOPMENT OF OCCLUSION IN PEDIATRIC DENTISTRY
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
CNN-based plastic waste detection system
CNN-based plastic waste detection systemCNN-based plastic waste detection system
CNN-based plastic waste detection system
 
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the HeartCardiac Impulse: Rhythmical Excitation and Conduction in the Heart
Cardiac Impulse: Rhythmical Excitation and Conduction in the Heart
 

CORONARY ARTERY DISEASE.pptx

  • 1. REGENCY INSTITUTE OF NURSING TOPIC- CORONARY ARTERY DISEASE BY- SHREYA YADAV NURSING TUTOR MEDICAL SURGICAL NURSING
  • 2. DEFINITION  Coronary artery disease is the narrowing or blockage of the coronary arteries, usually caused by atherosclerosis.  CAD is a progressive disease process characterized by narrowing or blockage of coronary artery resulting in decreased blood flow to the heart muscle.
  • 3. RISK FACTOR MODIFIABLE RISK FACTORS:  Tobacco use  High blood cholesterol or triglyceride levels  Lack of exercise  Obesity  Stress  Use of oral contraceptive  Infection  Hypertension NONMODIFIABLE RISK FACTORS:  Family history of heart disease  Age (45-55)
  • 4.  Gender CLINICAL MANIFESTATION:  Ischemia  Low cardiac output  Bradycardia (Decrease pulse rate)  Hypertension  Myocardial infarction  Diaphoresis –excessive sweating  ECG changes – ST segment and T wave changes, also show tachycardia, bradcardia, or dysrhythimas.  Dysarrithmias
  • 5.  Decreased urine output.  Nausea And Vomiting  Skin- Cool, Clammy ,Diaphoretic , And Pale Appearance On Skin. DIAGNOSTIC EVALUATION: History collection Physical examination Stress test
  • 7. ECG
  • 10. MANAGEMENT MEDICAL MANAGEMENT Vasodilators (These drugs acts as blood vessel dilator): Nitrates. Beta-Blockers (Decrease work load in heart): Propranolol 20-40 mg. Calcium channel blocker They improve coronary blood flow:  Nifedipine  Verapamil
  • 11. Anti-hypertensive drugs  Methyldopa, Sodium nitroprusside, Amlodipine. ACE inhibitor  Captopril, Enolapril SURGICAL MANAGEMENT • Percutaneous transluminal coronary angioplasty(PTCA). • Coronary artery bypass graft surgery(DCA). • Intra coronary stent. NURSING MANAGEMENT • Assess pain • Assess vital sign • Ensure bed rest • Continuous cardiac monitoring
  • 12. Angina Pectoris Angina pectoris is a sudden attacks of chest pain or discomfort caused by deficient oxygenation of the heart muscles usually due to impaired blood flow to the heart
  • 13.
  • 14. Modifiable risk factor:  Tobacco use  High blood cholesterol or triglyceride levels  Lack of exercise  Obesity  Stress NON MODIFIABLE RISK FACTORS:  Family history of heart disease  Age  Gender
  • 15. CLINICAL MANIFESTATION: Sensation of chest pain. Ischemia- Ischemia is a restriction in blood supply to tissues, causing a shortage of oxygen that is needed for cellular. Low cardiac output Decrease pulse rate. BP may be elevated because of sympathetic stimulation or decreased BP because of decreased contractility. Myocardial infarction Diaphoresis –excessive sweating ECG changes – ST segment and T wave changes
  • 16.  Pulmonary edema  Chest heaviness  Dyspnea- difficulity of breathing  Fatigue  Gastrointestinal- Nausea And Vomiting  Skin- Cool, Clammy ,Diaphoretic , And Pale Appearance On Skin DIAGNOSTIC EVALUATION: • History collection • Stress test • Electrocardiogram(ECG) • Echocardiogram • Angiogram
  • 17. MANAGEMENT Can be used to treat coronary artery disease, including:  Vasodilators (These drugs acts as blood vessel dilator):  Nitrates  Beta-Blockers (Decrease work load in heart): • Propranolol 20-40 mg  Calcium channel blocker (They improve coronary blood flow): Nifedipine , Verapamil
  • 18. Atheriosclerosis Atherosclerosis is the most common disease of the arteries; the term means “hardening of the arteries. It is the diffuse process whereby the muscle fibers and the endothelial lining of the walls of small arteries and arterioles become thickened.
  • 19. Risk Factor-  High blood pressure  High cholesterol  High triglycerides, a type of fat (lipid) in your blood  Smoking and other sources of tobacco  Insulin resistance, obesity or diabetes  A family history of early heart disease  Lack of exercise
  • 20. CLINICAL MANIFESTATION-  Pain is the first symptom that occurs  Pain generally occurs in the affected extremity in conjunction w/sustained activity. This is due to the demand of the tissue exceeding the available blood supply.  Heart failure  Increased cardiac enzyme level  Sudden cardiac death  Dyspnea  Inadequate cardiac output  Ischemia of heart muscles  Difficulty in speaking  Arrythmias  Palpitation  Diaphoresis  Myocardial infraction
  • 21.  Diagnostic Evaluation-  History collection – The family history, nutritional history and personal history should be collected from the patient.  Physical examination  Blood studies  Electrocardiogram (ECG)  Angiogram  CT-Scan
  • 22. MANAGEMENT- Pharmacological management-  Anti-platelet medications. Such as aspirin(75-100mg,orally).  Beta blocker medications Eg: propanolol (20-40 mg).  Angiotensin-converting enzyme (ACE) inhibitors.. Eg: captopril(25 mg orally) ramipril(20mg orally).  Calcium channel blockers. Eg: verapamil amlodipin (5-20 mg IV). Surgical Management:  Coronary Artery Bypass Surgery. (CABG)  Thrombectomy  Embolectomy
  • 23. MYOCARDIAL INFRACTION Myocardial Infarction is defined as a disease caused by reduced blood flow in a coronary artery due to atherosclerosis & occlusion of an artery an embolus or thrombus.
  • 24. Types of Myocardial infarction- According to wall-  Anterior wall MI- obstruction of left anterior descending artery (LAD) results in anterior or septal wall MI  Posterior wall MI – Obstruction of circumflex artery results in posterior wall MI.  Inferior wall MI- obstruction of the right coronary artery results in inferior wall MI. According to ECG  ST-Elevated Myocardial infarction  Non- ST Elevated Myocardial Infarction
  • 25. RISK FACTORS Non- Modifiable Risk Factors:  Age(45-55)  Gender  Sex (Male)  Genetics Modifiable Risk Factors:  Tobacco use  High blood cholesterol or triglyceride levels  Lack of exercise  Obesity  Stress  Use of oral contraceptive  Infection  Hypertension
  • 26. CLINICAL MANIFESTATION  Chest pain characterized by  heavy, vise like pain which radiates to shoulders and down the arms, usually the left arms  occur during rest and during exertion  not relieved by rest long lasts longer than 30 min.  No relief with nitrites  Shortness of breath  Pallor  Cold clammy skin  Diaphoresis  Dizziness  Light headedness  Nausea  Vomiting  Fainting  Shock  Profuse sweating  Fever after 48 hour of MI  Pulse normal often rapid or irregular  Anxiety
  • 27. DIAGNOSTIC EVALUATION  History collection  Physical examination  Electrocardiogram  Echocardiogram  Cardiac marker-  Myoglobin-The myoglobin level starts to increase within 1 to 3 hours and peaks within 12 hours after the onset of symptoms.  Troponin- Troponin I and T are specific for cardiac muscle, an increase in the level of troponin in the serum can be detected within a few hours during acute MI.  Creatine Kinase and Its Isoenzymes-There are three creatine kinase (CK) isoenzymes: CK-MM (skeletal muscle), CK-MB (heart muscle), and CK-BB (brain tissue).
  • 28. MANAGEMENT- MEDICAL MANAGEMENT- Pharmacological management-  Opiate Analgesic - Morphine (2.5-5.0mg, IV) - For sudden relief of pain & anxiety.  Aspirin (162-325mg,Orally)- for prevention of thrombus extension, embolism, venous thrombosis  Vasodilators- Nitrates (0.4 mg , sublingual)  Anticoagulant- Heparin (5000 U,IV)  Antihypertensive drugs-Methyldopa- (250 mg. orally), B- blocker- Propanolol(20- 40 mg).
  • 29. Non-pharmacological management-  Avoiding tobacco smoking, eating a well-balanced diet that is low in saturated fat and refined carbohydrates.  Cessation of smoking should be given priority in risk-factor reduction.  Regular physical activity reduces the incidence of, and fatality rate from, cardiovascular disease. Surgical management-  Coronary artery bypass graft surgery (CABG)  (PTCA) percutaneous transluminal coronary angioplasty - a small, flexible plastic tube, or catheter, with a "balloon" at the end of it. When the tube is in place, it inflates to open the blood vessel.  Atherectomy
  • 30. NURSING MANAGEMENT: - Assess vita sign of the patient. - Assess for the chest pain where it radiates - Advice to do not smoke and drink alcohol. - Change the position to maintain blood circulation. - Provide adequate bed rest.
  • 31. NURSING DIAGNOSIS  Acute Pain related to decreased/increased cardiac output as evidenced by verbalization.  Ineffective breathing pattern related to decreased blood flow to pulmonary capillaries secondary to decreased ventricular contractility as evidenced by vital sign.  Impaired tissue perfusion related to decreased cardiac output as evidence by vital sign.  Fear and anxiety related to disease condition as evidence by facial expression.  Knowledge deficit related to prognosis and self care management as evidence patient is asking more question.